Wuhan Wuyao Pharmaceutical Co., Ltd is a holding subsidiary established by Wuhan Grand Pharmaceutical Group Co., Ltd (the former Wuhan Pharmaceutical Co., Ltd) in 2002. It is a hi-tech enterprise which is engaged in the production and business of medical raw materials. The company is located in No.5 Gutian Rd., Wuhan City. The main products of the company include the more than 40 types of medical raw materials and intermediate products like Metamizole Sodium Tablet, Metronidazole Tablet, Pirenoxine Sodium eye drops, Amidopyrine, Noradrenalini Bitartas, and Epinephfine. It has an annual production capacity of over 4000 tons, and annual sales revenue over 180 million yuan. The annual output of Metamizole Sodium Tablet is over 3,600 tons, ranking second in the nation; Tirofiban Hydrochloride and sodium chloride Injection and Enoxacin Tablet produced by our company belong to the National Category ??New Drug, and Pirenoxinesodium Eye Drops, Adrenaline and Noradrenaline Bitartrate are unique products in the nation. Our products not only sell well in China, but also exported to more than 20 countries and regions in Europe and Asia, with a total output value of over 10 million dollars. ???With a professional technician team with powerful strength and strong complementarity, the company has gradually developed seven types of new drugs like Lansoprazole. The company organizes production in strict accordance with the GMP requirements and its main products have passed the GMP Certification, in which Adrenaline has passed the certification of United States Food and Drug Administration (FDA). The company has formed the core competitive edge with comparative advantages in line with the systems and regulations of the modern enterprise and by changing the operational mechanism and adhering to the implementation of the brand strategy. uild a century-old pharmaceutical enterprise to repay the society is our social mission.